☆ 4.7 Article

Targeting miR-30d reverses pathological cardiac hypertrophy

EBIOMEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Cardiac & Cardiovascular Systems

Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy

Ren Jie Phang et al.

Summary: Patients with Type 2 diabetes often suffer from a distinct cardiac condition called diabetic cardiomyopathy, which is not well understood and has limited treatment options. This review focuses on the roles of non-myocyte cells in the heart and the potential use of sodium-glucose cotransporter 2 inhibitors as a therapy for diabetic cardiomyopathy.

CARDIOVASCULAR RESEARCH (2023)

添加到收藏夹

Article Biotechnology & Applied Microbiology

miR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection

Yihua Bei et al.

Summary: miR-486 plays a protective role in cardiac ischemia/reperfusion (I/R) injury by targeting PTEN and FoxO1 and activating the AKT/mTOR pathway to inhibit cardiomyocyte apoptosis. miR-486 is essential for exercise-induced myocardial protection.

MOLECULAR THERAPY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes

Shawn Veitch et al.

Summary: The study found that an increase in miR-30d and miR-30e is associated with coronary microvascular dysfunction, rarefaction, and the development of heart failure with preserved ejection fraction in T2D models. These miRNAs may serve as early biomarkers and potential therapeutic targets, reflecting altered endothelial cell fatty acid metabolism and microvascular dysfunction in the diabetic heart.

CARDIOVASCULAR DIABETOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Small Extracellular Vesicles From Brown Adipose Tissue Mediate Exercise Cardioprotection

Hang Zhao et al.

Summary: This study found that BAT participates in regulating cardiomyocyte survival and exercise cardioprotection through the secretion of sEVs. The study also identified BAT miRNAs as essential components for mediating cardioprotection and revealed their mechanism of action involving suppression of the MAPK pathway.

CIRCULATION RESEARCH (2022)

添加到收藏夹

Article Hospitality, Leisure, Sport & Tourism

Exercise attenuates angiotensinII-induced muscle atrophy by targeting PPARy/miR-29b

Qi Liu et al.

Summary: Exercise attenuates AngII-induced muscle atrophy by activation of PPARy and suppression of miR-29b.

JOURNAL OF SPORT AND HEALTH SCIENCE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling

Jin Li et al.

Summary: miR-30d can improve cardiac function and reduce fibrosis by targeting MAP4K4 and integrin alpha 5, showing a protective effect in ischemic heart failure. The communication of extracellular vesicle-contained miRNAs may provide a novel therapeutic target in heart failure treatment.

CIRCULATION RESEARCH (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

MicroRNA-151 Attenuates Apoptosis of Endothelial Cells Induced by Oxidized Low-density Lipoprotein by Targeting Interleukin-17A (IL-17A)

Fanfeng Chen et al.

Summary: This study investigated the mechanism of miR-151 and IL-17A in apoptosis of atherosclerotic endothelial cells. The results showed that miR-151 and si-IL-17A inhibited the apoptosis rate of aortic endothelial cells treated by Ox-LDL by reducing the expression levels of apoptotic proteins and increasing the expression levels of anti-apoptotic protein Bcl-2. MiR-151 was found to inhibit endothelial cell apoptosis in AS, and IL-17A was identified as a new target for miR-151.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Inhibition of lncRNA MAAT Controls Multiple Types of Muscle Atrophy by cis- and trans-Regulatory Actions

Jin Li et al.

Summary: lncMAAT is identified as a common regulator of skeletal muscle atrophy, which is downregulated in multiple models and can ameliorate muscle atrophy by negatively regulating miR29b and positively regulating Mbnl1 expression. Overexpression of lncMAAT may represent a promising therapy for muscle atrophy induced by different stimuli.

MOLECULAR THERAPY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

miR-30d-5p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma

Liang Liang et al.

Summary: miR-30d-5p downregulation in renal cell carcinoma leads to overexpression of ATG5, inhibiting cell proliferation and autophagy while increasing apoptosis. This finding may provide a basis for the development of novel cancer therapeutics.

FEBS OPEN BIO (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b

Jin Li et al.

Summary: The study identified PPAR gamma as a negative regulator of miR-29b, which can suppress AngII-induced muscle atrophy. Inhibiting miR-29b can prevent muscle atrophy, while overexpression of miR-29b target genes can rescue muscle atrophy induced by AngII.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

添加到收藏夹

Article Neurosciences

被撤回的出版物: Knockdown EZH2 attenuates cerebral ischemia-reperfusion injury via regulating microRNA-30d-3p methylation and USP22 (Retracted article. See vol. 188, pg. 38, 2022)

Dianshi Jin et al.

Summary: This study found that increasing miR-30d-3p levels and reducing EZH2 levels in mice with cerebral ischemia-reperfusion injury can promote walking coordination, learning and memory ability, decrease neurological injury score, improve oxidative stress injury, reduce cerebral infarction area, and cell apoptosis. Additionally, EZH2 targets USP22 by promoting miR-30d-3p methylation, indicating a potential candidate for treatment of cerebral ischemia-reperfusion injury.

BRAIN RESEARCH BULLETIN (2021)

添加到收藏夹

Article Immunology

Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period

Caroline Frorup et al.

Summary: Circulating miRNA levels in plasma extracellular vesicles from lactating mothers with type 1 diabetes differ significantly from healthy mothers, potentially impacting disease pathogenesis and inflammatory responses.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Serum microRNA-30d is a sensitive biomarker for angiotensin II-induced cardiovascular complications in rats

Masaki Morishima et al.

Summary: The study was conducted to test the hypothesis that Ang II-induced cardiovascular complications can be distinguished from catecholamine-induced ones in rats based on their serum circulating biomarkers. It was found that serum microRNA-30d is a sensitive biomarker for Ang II-induced complications, while it is postulated that Ang II-induced cardiomyocyte hypertrophy may be independent of miR-30d/BNP signaling pathways.

HEART AND VESSELS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Elevated EZH2 in ischemic heart disease epigenetically mediates suppression of NaV1.5 expression

Limei Zhao et al.

Summary: In ischemic hearts, EZH2 is increased and epigenetically suppresses Scn5a transcription by H3K27me3, leading to decreased NaV1.5 expression and Na+ channel activity. Inhibition of EZH2 can enhance NaV1.5 expression and increase Na+ channel activity.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Dickkopf 3: a Novel Target Gene of miR-25-3p in Promoting Fibrosis-Related Gene Expression in Myocardial Fibrosis

Ni Zeng et al.

Summary: miR-25-3p enhances cardiac fibrosis by suppressing Dkk3 to activate Smad3 and fibrosis-related gene expression.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)

添加到收藏夹

Article Medicine, Research & Experimental

MicroRNA-30 regulates left ventricular hypertrophy in chronic kidney disease

Jingfu Bao et al.

Summary: In CKD rats, restoration of cardiomyocyte-specific miRNA-30 helps to alleviate LVH, while blockade of miRNA-30 leads to cardiomyocyte hypertrophy. CKD-related factors suppress cardiac miRNA-30 expression, while supplementation of miRNA-30 mitigates cardiomyocyte hypertrophy induced by these factors.

JCI INSIGHT (2021)

添加到收藏夹

Article Veterinary Sciences

Expression Profile of Circulating MicroRNAs in Dogs With Cardiac Hypertrophy: A Pilot Study

Woong-Bin Ro et al.

Summary: This study identified 11 differentially expressed circulating microRNAs related to MMVD or PS in dogs. These microRNAs could potentially serve as novel biomarkers or therapeutic targets for cardiac hypertrophy in dogs.

FRONTIERS IN VETERINARY SCIENCE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?

Maaike te Lintel Hekkert et al.

Summary: A study was conducted to test the efficacy of DMX-10001, a pro-drug of DMX-5804, in reducing infarct size in large-mammal myocardial infarction. Despite exceeding the concentrations proven successful in mice and hPSC-CMs, DMX-10001 failed to reduce infarct size in large-mammals.

BASIC RESEARCH IN CARDIOLOGY (2021)

添加到收藏夹

Article Peripheral Vascular Disease

Percutaneous Intracoronary Delivery of Plasma Extracellular Vesicles Protects the Myocardium Against Ischemia-Reperfusion Injury in Canis

Hongyun Wang et al.

Summary: Plasma circulating extracellular vesicles have potential therapeutic benefits for ischemic diseases, but the delivery method is crucial. Studies using large animal and murine models, as well as human embryonic stem cells or rat cardiomyocytes, identified the role and delivery methods of EVs in ischemia-reperfusion injury. Additionally, the crucial molecule miR-486 within EVs was found to confer cardioprotective effects.

HYPERTENSION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

Jorg Taubel et al.

Summary: The study evaluated the safety and mechanism of action of CDR132L in patients with chronic ischemic heart failure, showing that CDR132L is safe and well tolerated, effectively reducing miR-132 levels and improving cardiac function.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

Jorg Taubel et al.

Summary: The first-in-class miR-132 inhibitor, CDR132L, showed good safety and tolerability in HF patients. It effectively reduced miR-132 levels, decreased NT-proBNP levels, and potentially improved cardiac function.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Review Hospitality, Leisure, Sport & Tourism

The roles of microRNA in redox metabolism and exercise-mediated adaptation

Ferenc Torma et al.

JOURNAL OF SPORT AND HEALTH SCIENCE (2020)

添加到收藏夹

Article Oncology

FBXW7 promotes pathological cardiac hypertrophy by targeting EZH2-SIX1 signaling

Weinian Gao et al.

EXPERIMENTAL CELL RESEARCH (2020)

添加到收藏夹

Article Physiology

Inhibition of EZH2 attenuates coronary heart disease by interacting with microRNA-22 to regulate the TXNIP/nuclear factor-κB pathway

Yong Liu et al.

EXPERIMENTAL PHYSIOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study

Wesley Tyler Abplanalp et al.

NUCLEIC ACID THERAPEUTICS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4

Pelin A. Golforoush et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Medicine, Research & Experimental

The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure

Qiulian Zhou et al.

THERANOSTICS (2020)

添加到收藏夹

Article Medicine, Research & Experimental

EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer

Huilong Yin et al.

THERANOSTICS (2020)

添加到收藏夹

Article Cell & Tissue Engineering

MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo

Lorna R. Fiedler et al.

CELL STEM CELL (2019)

添加到收藏夹

Article Peripheral Vascular Disease

GRP78 (Glucose-Regulated Protein of 78 kDa) Promotes Cardiomyocyte Growth Through Activation of GATA4 (GATA-Binding Protein 4)

Guangyu Zhang et al.

HYPERTENSION (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

RNA-based diagnostic and therapeutic strategies for cardiovascular disease

Dongchao Lu et al.

NATURE REVIEWS CARDIOLOGY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

MicroRNAs in Cardiac Hypertrophy

Nadine Wehbe et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation

Shuai Song et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)

添加到收藏夹

Article Cell Biology

Inhibition of Smurf2 translation by miR-322/503 protects from ischemia-reperfusion injury by modulating EZH2/Akt/GSK3β signaling

Wei Dong et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Mechanisms of physiological and pathological cardiac hypertrophy

Michinari Nakamura et al.

NATURE REVIEWS CARDIOLOGY (2018)

添加到收藏夹

Article Oncology

miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes

Martine Croset et al.

CANCER RESEARCH (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

MiRNA-based Therapeutics for Lung Cancer

Miaowei Wu et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

添加到收藏夹

Article Cell Biology

Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure

Junjie Xiao et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

添加到收藏夹

Article Cell Biology

Regulation of Insulin Resistance by Multiple MiRNAs via Targeting the GLUT4 Signalling Pathway

Tong Zhou et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)

添加到收藏夹

Article Oncology

MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer

Di Chen et al.

CANCER LETTERS (2015)

添加到收藏夹

Article Cell Biology

miR-222 Is Necessary for Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling

Xiaojun Liu et al.

CELL METABOLISM (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis A Translational Pilot Study

Yonathan F. Melman et al.

CIRCULATION (2015)

添加到收藏夹

Review Chemistry, Medicinal

miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart

Bianca C. Bernardo et al.

FUTURE MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Article Oncology

EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis

Pingyu Zhang et al.

JOURNAL OF PATHOLOGY (2014)

添加到收藏夹

Article Cell Biology

MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy

X. Li et al.

CELL DEATH & DISEASE (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2

Anika Tschirner et al.

ESC HEART FAILURE (2014)

添加到收藏夹

Article Cell & Tissue Engineering

Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes

Shugo Tohyama et al.

CELL STEM CELL (2013)

添加到收藏夹

Review Biotechnology & Applied Microbiology

MicroRNAs and other non-coding RNAs as targets for anticancer drug development

Hui Ling et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer

S-F Su et al.

ONCOGENE (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

MicroRNA-30d Induces Insulin Transcription Factor MafA and Insulin Production by Targeting Mitogen-activated Protein 4 Kinase 4 (MAP4K4) in Pancreatic β-Cells

Xiaomin Zhao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

添加到收藏夹

Article Endocrinology & Metabolism

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study

Lei Kong et al.

ACTA DIABETOLOGICA (2011)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

CaMKII Negatively Regulates Calcineurin-NFAT Signaling in Cardiac Myocytes

Scott M. MacDonnell et al.

CIRCULATION RESEARCH (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification of glucose-regulated miRNAs from pancreatic β cells reveals a role for miR-30d in insulin transcription

Xiaoqing Tang et al.

RNA (2009)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy

BJ Wilkins et al.

CIRCULATION RESEARCH (2004)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Calcineurin and beyond - Cardiac hypertrophic signaling

JD Molkentin

CIRCULATION RESEARCH (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.